| 标题 |
Isatuximab plus bortezomib, lenalidomide, and dexamethasone for transplantineligible newly diagnosed multiple myeloma patients: a frailty subgroup analysis of the IMROZ trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Haematologica 作者:Salomon Manier; Meletios-Athanasios Dimopoulos; Xavier P. Leleu; Philippe Moreau; Michele Cavo; et al 出版日期:2025-03-20 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)